At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
VERU Veru Inc.
Not Yet Opened 10-29 16:00:00 EDT
2.23
-0.04
-1.76%
盘后2.25
+0.02+0.74%
19:30 EDT
High2.33Low2.22Vol56.94K
Open2.27D1 Closing2.27Amplitude4.85%
Mkt Cap38.02MTradable Cap34.52MTotal Shares17.05M
T/O128.13KT/O Rate0.37%Tradable Shares15.48M
P/B--ROE--EPS0.00
52wk High--52wk Low--P/E--
Dividend--Div.Yield--ROA--

Loading ...

A 42% Risk Reduction—and an 18% Stock Drop
Bellwether Stocks Movement  ·  10-24
A 42% Risk Reduction—and an 18% Stock Drop
One Failed Endpoint Just Erased Most of EyePoint’s Value
Bellwether Stocks Movement  ·  10-20
One Failed Endpoint Just Erased Most of EyePoint’s Value
Novartis’ Pipeline Is Cracking—And The Stock Isn’t
Bellwether Stocks Movement  ·  10-17
Novartis’ Pipeline Is Cracking—And The Stock Isn’t
From Algorithms To Oncology: Why IAM Jumped On Day One
Bellwether Stocks Movement  ·  10-16
From Algorithms To Oncology: Why IAM Jumped On Day One
Inflation Shock Sends Wall Street Lower—Why Big Pharma Became The Market’s Refuge
Sector Pulse  ·  10-16
Inflation Shock Sends Wall Street Lower—Why Big Pharma Became The Market’s Refuge
Pharma Stocks Jump. Eli Lilly, AstraZeneca up over 4%; Novo Nordisk up over 3%; Moderna, J&J, Merck, Pfizer up over 2%
Tiger Newspress  ·  10-15
Pharma Stocks Jump. Eli Lilly, AstraZeneca up over 4%; Novo Nordisk up over 3%; Moderna, J&J, Merck, Pfizer up over 2%
US Stocks on the MOVE-Netflix, Coinbase Global, Accenture
Reuters  ·  10-15
US Stocks on the MOVE-Netflix, Coinbase Global, Accenture
Oppenheimer Upbeat on Veru, Says 'come for the Lean Mass, Stay for the Muscle Function'
Reuters  ·  10-14
Oppenheimer Upbeat on Veru, Says 'come for the Lean Mass, Stay for the Muscle Function'
Why Vaxcyte Chose A 1.5% Convertible
Macro World​  ·  10-07
Why Vaxcyte Chose A 1.5% Convertible
Veru Initiated at Buy by WestPark Capital
Dow Jones  ·  10-07
Veru Initiated at Buy by WestPark Capital
Veru initiated with a Buy at WestPark Capital
TIPRANKS  ·  10-07
Veru initiated with a Buy at WestPark Capital
From Lilly Deal to Market Darling: Inside Ginkgo's 120% Monthly Run
Bellwether Stocks Movement  ·  10-06
From Lilly Deal to Market Darling: Inside Ginkgo's 120% Monthly Run
One Molecule, Three Diseases, $1.55 Billion — Inside CSL's Bet
Bellwether Stocks Movement  ·  10-05
One Molecule, Three Diseases, $1.55 Billion — Inside CSL's Bet
Merck Doubled Off Its Lows — And Analysts Still See More Room
Bellwether Stocks Movement  ·  10-05
Merck Doubled Off Its Lows — And Analysts Still See More Room
CSL Bets $1.6 Billion on a Drug That Hasn't Finished Phase 2
Bellwether Stocks Movement  ·  10-05
CSL Bets $1.6 Billion on a Drug That Hasn't Finished Phase 2
Bayer Bets $2.2 Billion That America Is Still The Best Place To Make Drugs
Macro World​  ·  10-03
Bayer Bets $2.2 Billion That America Is Still The Best Place To Make Drugs
23.3% Vs 14.8%: Lilly's New Data Just Changed The Obesity Drug Playbook
Bellwether Stocks Movement  ·  10-03
23.3% Vs 14.8%: Lilly's New Data Just Changed The Obesity Drug Playbook
Novartis Bets $7.8 Billion On MRNA Beyond Vaccines
Options & Short Sell  ·  10-02
Novartis Bets $7.8 Billion On MRNA Beyond Vaccines
AstraZeneca To Invest $2 Billion In Summit And Co-Develop Drugs; Shares Jump After Hours
Options & Short Sell  ·  09-29
AstraZeneca To Invest $2 Billion In Summit And Co-Develop Drugs; Shares Jump After Hours
Pharmaceutical Stocks Jump. Moderna, Eli Lilly up over 3%; Novavax, Pfizer up Around 2%; Merck, Novo Nordisk up over 1%
Tiger Newspress  ·  09-24
Pharmaceutical Stocks Jump. Moderna, Eli Lilly up over 3%; Novavax, Pfizer up Around 2%; Merck, Novo Nordisk up over 1%

Introduction

Company Name.
Veru Inc.
Affiliated Markets:
NASDAQ
Listing Date:
--
Main Business:
Veru Inc., a late clinical stage biopharmaceutical company, focuses on developing medicines for treatment of metabolic diseases, oncology, and acute respiratory distress syndrome (ARDS). Its marketed products comprise FC2 female condom for the dual protection against unplanned pregnancy and the transmission of sexually transmitted infections. The company's development program includes enobosarm, a selective androgen receptor modulator for treatment of augment fat loss and to prevent muscle loss in sarcopenic obese and overweight elderly patients; Enobosarm, a selective androgen receptor modulator for the treatment of AR+ ER+ HER2- metastatic breast cancer; and sabizabulin, a microtubule disruptor for the treatment of hospitalized patients with viral lung infection on oxygen support who are at high risk for viral induced ARDS and death. The company was formerly known as The Female Health Company and changed its name to Veru Inc. in July 2017. Veru Inc. was incorporated in 1971 and is headquartered in Miami, Florida.
Issue price:
--